HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matias Ostrowski Selected Research

Carcinoma (Carcinomatosis)

10/2012Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matias Ostrowski Research Topics

Disease

4HIV Infections (HIV Infection)
01/2021 - 01/2014
4Infections
01/2019 - 09/2005
2Hypoxia (Hypoxemia)
11/2020 - 11/2018
2Neoplasms (Cancer)
10/2012 - 02/2008
1Ischemia
11/2020
1Gliosis
11/2020
1Demyelinating Diseases (Demyelinating Disease)
11/2020
1Acidosis
01/2019
1Inflammation (Inflammations)
11/2018
1Carcinoma (Carcinomatosis)
10/2012
1Fibrosarcoma
02/2008

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2008
2DNA (Deoxyribonucleic Acid)IBA
11/2018 - 02/2008
2Glucose (Dextrose)FDA LinkGeneric
01/2017 - 01/2014
2CytokinesIBA
10/2012 - 09/2005
1histidine-rich proteinsIBA
01/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1Blood Proteins (Serum Proteins)IBA
01/2019
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2019
1Interferon-gamma (Interferon, gamma)IBA
11/2018
1Transcription Factors (Transcription Factor)IBA
11/2018
1Interleukin-6 (Interleukin 6)IBA
11/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2018
1Metalloproteases (Metalloproteinases)IBA
10/2012
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2012
1Histocompatibility Antigens Class IIBA
02/2008
1AutoantigensIBA
02/2008
1Neoplasm Antigens (Tumor Antigens)IBA
02/2008
1AntigensIBA
02/2008
1Neutralizing AntibodiesIBA
09/2007
1Interleukin-10 (Interleukin 10)IBA
09/2005

Therapy/Procedure

2Highly Active Antiretroviral Therapy (HAART)
10/2017 - 01/2017
1Intranasal Administration
11/2020